Page last updated: 2024-10-27

fluorouracil and Atherosclerotic Parkinsonism

fluorouracil has been researched along with Atherosclerotic Parkinsonism in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergevin, PR1
Patwardhan, VC1
Weissman, J1
Lee, SM1

Other Studies

1 other study available for fluorouracil and Atherosclerotic Parkinsonism

ArticleYear
Letter: Neurotoxicity of 5-fluorouracil.
    Lancet (London, England), 1975, Feb-15, Volume: 1, Issue:7903

    Topics: Adenocarcinoma; Aged; Colonic Neoplasms; Fluorouracil; Humans; Injections, Intravenous; Male; Parkin

1975